🇺🇸 FDA
Patent

US 9409662

Formulations of albu-BChE, preparation and uses thereof

granted A61KA61K38/385A61K38/465

Quick answer

US patent 9409662 (Formulations of albu-BChE, preparation and uses thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/385, A61K38/465, A61P, A61P25/36